Skip to main content

SPHERA FUNDS MANAGEMENT LTD.

Position in APRE — Aprea Therapeutics, Inc.

CIK 1496201 TEL AVIV, L3

Position in APRE

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$216,540
+$10,530 QoQ
Shares Held
270,000
0.0% QoQ
Ownership
2.14%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#3
of 28 holders
Holding Since
Jun 2020
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in APRE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SPHERA FUNDS MANAGEMENT LTD. holds $446,002,188 across 71 Biotechnology names. APRE ranks #69 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in APRE

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $216,540 270,000
2026-03-31 $206,010 270,000
2025-12-31 $230,310 270,000
2025-09-30 $398,250 270,000
2025-06-30 $456,300 270,000
2025-03-31 $550,800 270,000
2024-12-31 $888,300 270,000
2024-09-30 $742,500 270,000
2024-06-30 $1,098,900 270,000
2024-03-31 $1,806,300 270,000
2020-06-30 $6,138,447 158,289